A patient taking isoniazid for tuberculosis develops peripheral neuropathy. What is the mechanism of this adverse effect?
-
A
Isoniazid competes with pyridoxine (vitamin B6) for binding to apoenymes
-
B
Isoniazid induces CYP2E1 producing hepatotoxic metabolites that damage peripheral nerves
-
C
Isoniazid directly inhibits myelin basic protein synthesis in Schwann cells
-
D
Isoniazid chelates magnesium required for axonal conduction